Abeona Therapeutics Board Member Michael Amoroso Resigns
ABEO sits 37% above its 52-week low of $4.
Summary
Michael Amoroso has resigned from Abeona Therapeutics' Board of Directors and its Nominating and Corporate Governance Committee, effective June 11, 2026. The company stated his departure was for personal reasons and not due to any disagreement with company operations or policies. While a board change is always noted, the stated reason mitigates concerns, especially following recent positive financial results and pipeline updates, including strong Q1 2026 revenue for ZEVASKYN.
At the time of this announcement, ABEO was trading at $5.49 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $315.2M. The 52-week trading range was $4.00 to $7.54. This news item was assessed with neutral market sentiment and an importance score of 7 out of 10. Source: Wiseek News.